PFE - What's Going On With Penny Stock AgeX Therapeutics? | Benzinga
Serina Therapeutics Inc, a privately held, clinical-stage biotechnology company, entered into a License Agreement under which Pfizer Inc (NYSE: PFE) will license, on a non-exclusive basis, Serina's POZ polymer technology.
Serina is focused on developing its proprietary POZ Platform drug delivery technology, including POZ lipid nanoparticle (LNP) delivery systems for RNA-based therapeutics.
"We are excited about the license to Pfizer for ...